نتائج البحث - "Victor Sarradin"

المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Fédérale Toulouse Midi-Pyrénées, Fournié, jean-jacques, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: JCI Insight
JCI Insight, 2021, 6 (2), ⟨10.1172/jci.insight.142513⟩
JCI Insight, Vol 6, Iss 2 (2021)
JCI Insight, American Society for Clinical Investigation, 2021, 6 (2), ⟨10.1172/jci.insight.142513⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Lymphocyte, [SDV]Life Sciences [q-bio], Lymphocyte Cooperation, Programmed Cell Death 1 Receptor, Immunology, T cells, Gene Expression, Uterine Cervical Neoplasms, Cancer immunotherapy, CD8-Positive T-Lymphocytes, In Vitro Techniques, Biology, Lymphocyte Activation, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Antigens, Neoplasm, Immune Tolerance, medicine, Humans, Cytotoxic T cell, RNA, Messenger, CD154, Ovarian Neoplasms, Immunity, Cellular, Apyrase, T-Lymphocytes, Helper-Inducer, General Medicine, Dendritic cell, Immune checkpoint, Tumor antigen, [SDV] Life Sciences [q-bio], 030104 developmental biology, medicine.anatomical_structure, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Cancer research, Medicine, Female, Tumor Escape, Cytokine secretion, CD8, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4d843042bee75d1bda7779727348c6Test
https://hal.science/hal-03365487Test

5

Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies

المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], Université Fédérale Toulouse Midi-Pyrénées, Centre National de la Recherche Scientifique - CNRS (FRANCE), Institut National de la Santé et de la Recherche Médicale - INSERM (FRANCE), Université Toulouse III - Paul Sabatier - UT3 (FRANCE), Institut Claudius Regaud - ICR (FRANCE), Centre Hospitalier Universitaire de Toulouse - CHU Toulouse (FRANCE), Institut Universitaire du Cancer de Toulouse - Oncopole - IUCT (Toulouse, France), (OATAO), Open Archive Toulouse Archive Ouverte, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Cancer Immunology Research
Cancer Immunology Research, American Association for Cancer Research, 2020, 8 (7), pp.869-882. ⟨10.1158/2326-6066.CIR-19-0855⟩
Cancer Immunology Research, 2020, 8 (7), pp.869-882. ⟨10.1158/2326-6066.CIR-19-0855⟩

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, [SDV]Life Sciences [q-bio], Immunology, Population, Programmed Cell Death 1 Receptor, [SDV.CAN]Life Sciences [q-bio]/Cancer, CD8-Positive T-Lymphocytes, Lymphocyte Activation, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, 03 medical and health sciences, Mice, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, CD28 Antigens, [SDV.CAN] Life Sciences [q-bio]/Cancer, Bystander effect, Medicine, Animals, Humans, Neoplasms, Glandular and Epithelial, education, Receptor, [SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity, Cell Proliferation, Cancer, education.field_of_study, Lymphocytes T, business.industry, CD28, Immune checkpoint, 3. Good health, Blockade, Mice, Inbred C57BL, Survival Rate, 030104 developmental biology, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, 030220 oncology & carcinogenesis, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Cancer research, Female, Single-Cell Analysis, business, Transcriptome, CD8